Abstract
The [1,2,4]triazolo[1,5-a]pyrimidines comprise a promising class of non-naturally occurring microtubule (MT)-active compounds. Prior studies revealed that different triazolopyrimidine substitutions can yield molecules that either promote MT stabilization or disrupt MT integrity. These differences can have important ramifications in the therapeutic applications of triazolopyrimidines and suggest that different analogues may exhibit different binding modes within the same site or possibly interact with tubulin/MTs at alternative binding sites. To help discern these possibilities, a series of photoactivatable triazolopyrimidine congeners was designed, synthesized and evaluated in cellular assays with the goal of identifying candidate probes for photoaffinity labeling experiments. These studies led to the identification of different derivatives that incorporate a diazirine ring in the amine substituent at position 7 of the triazolopyrimidine heterocycle, resulting in molecules that either promote stabilization of MTs or disrupt MT integrity. These photoactivatable candidate probes hold promise to investigate the mode of action of MT-active triazolopyrimidines.
References
Aug 12, 2006·Expert Review of Proteomics·David RobinetteChristoph H Borchers
Jan 19, 2007·Journal of Medicinal Chemistry·Nan ZhangCarl Beyer
Apr 10, 2007·Bioorganic & Medicinal Chemistry Letters·Nan ZhangCarl Beyer
Dec 2, 2008·Bioorganic & Medicinal Chemistry·Nan ZhangCarl Beyer
Jan 10, 2009·Cancer Chemotherapy and Pharmacology·Carl F BeyerJames J Gibbons
Mar 3, 2009·Journal of Neurochemistry·Nobuyuki FukushimaToshifumi Tsujiuchi
Oct 2, 2009·Pest Management Science·Patrick J CrowleyMarkus R Dobler
Apr 13, 2012·Bioorganic & Medicinal Chemistry·Clemens LamberthPeter Schneiter
Dec 12, 2012·Bioorganic & Medicinal Chemistry·Clemens LamberthAndy Corran
Jul 6, 2014·Journal of Medicinal Chemistry·Kevin LouCarlo Ballatore
Mar 31, 2015·Bioorganic & Medicinal Chemistry Letters·Anne-Sophie CornecKurt R Brunden
Mar 17, 2016·The Journal of Pharmacology and Experimental Therapeutics·Jane KovalevichKurt R Brunden
Jan 18, 2017·ACS Chemical Neuroscience·Carlo BallatoreAmos B Smith
Jun 6, 2017·Cell Chemical Biology·Gonzalo Sáez-CalvoJosé Fernando Díaz
Citations
Jul 4, 2018·ChemMedChem·Ludovica MontiCarlo Ballatore
Jun 20, 2020·Journal of Biomolecular Structure & Dynamics·Raj KamalSatyajit Beura
Nov 9, 2018·Molecular Neurodegeneration·Bin ZhangKurt R Brunden
Apr 26, 2021·European Journal of Medicinal Chemistry·Xian-Sen HuoPei-Liang Zhao
Nov 3, 2020·ACS Infectious Diseases·Ludovica MontiConor R Caffrey
Jan 8, 2021·Journal of Medicinal Chemistry·Killian OukoloffCarlo Ballatore
Nov 17, 2020·The Journal of Organic Chemistry·Shuang-Qi TangFrédéric Bihel